FUROSCIX® (furosemide injection) 80mg/10mL for subcutaneous use. Learn more about FUROSCIX® including Full Prescribing Information and important safety information.

Extending the reach and benefits of outpatient care through a variety of innovative and proprietary solutions in the pharmaceutical space
Areas of Focus
Continually advancing the medical and scientific understanding of our products
Products
Learn about careers at scPharmaceuticals.
Careers

Recent News

April 24, 2024

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

Read More
March 13, 2024

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Read More
March 06, 2024

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

Read More
February 28, 2024

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

Read More

All News